Top compounds associated with response to RNF165


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K66453893 CTRPv2 pan-cancer AAC 0.025 0.5
mRNA YL54 CTRPv2 pan-cancer AAC 0.032 0.5
mRNA Vinorelbine GDSC1000 pan-cancer AAC 0.024 0.5
mRNA PF-4708671 GDSC1000 pan-cancer AAC 0.023 0.5
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.028 0.5
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC 0.051 0.5
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.025 0.5
mRNA lenalidomide GDSC1000 pan-cancer AAC -0.024 0.5
mRNA OSI-027 CTRPv2 pan-cancer AAC 0.027 0.5
mRNA BRD1835 CTRPv2 pan-cancer AAC 0.027 0.5
Download CSV